ארצות הברית - אנגלית - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u), desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3) - ethinyl estradiol 0.03 mg - enskyce tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. in a clinical trial with enskyce, 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. this represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. this rate includes patients who did not take the drug correctly. emergency contraceptive pills: treatment initiated within 72 hours after unprotected intercourse reduces the risk of pregnancy by at least 75%.4 lactation amenorrhea method: lam is a high

ארצות הברית - אנגלית - NLM (National Library of Medicine)

bryant ranch prepack - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - volnea™ (desogestrel and ethinyl estradiol and ethinyl estradiol) tablets are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table 2 lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. table 2 percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year, united states. % of women experiencing an unintended pregnancy within the first year of use % of women continuing use at one year * method (1) typical use †(2) perfect use ‡ (3) (4) chance§ 85 85 spermicides¶ 26 6 40 periodic abstinence 25 63 calendar 9 ovulation method 3 sympto-thermal# 2 post-ovulation 1 withdrawal 19 4 capÞ parous women 40 26 42 nulliparous women 20 9 56 sponge parous women 40 20 42 nulliparous women 20 9 56 diaphragm 20 6 56 condomß female (reality) 21 5 56 male 14 3 61 pill 5 71 progestin only 0.5 combined 0.1 iud progesterone t 2 1.5 81 copper t 380a 0.8 0.6 78 lng 20 0.1 0.1 81 depo-provera 0.3 0.3 70 norplant and norplant-2 0.05 0.05 88 female sterilization 0.5 0.5 100 male sterilization 0.15 0.10 100 adapted from hatcher et al., 1998, ref#1. volnea is contraindicated in females who are known to have or develop the following conditions:

ארצות הברית - אנגלית - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u), desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3) - bekyree (desogestrel and ethinyl estradiol tablets usp and ethinyl estradiol tablets usp) are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. table ii: percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year, united states. among couples attempting to avoid pregnancy, the percentage who continue to use a method for one year. b    among typical couples who initiate use of a method (not necessarily for the first time), the per

קנדה - אנגלית - Health Canada

aspen pharmacare canada inc. - desogestrel; ethinyl estradiol; desogestrel; ethinyl estradiol; desogestrel; ethinyl estradiol - tablet - 0.1mg; 0.025mg; 0.125mg; 0.025mg; 0.15mg; 0.025mg - desogestrel 0.1mg; ethinyl estradiol 0.025mg; desogestrel 0.125mg; ethinyl estradiol 0.025mg; desogestrel 0.15mg; ethinyl estradiol 0.025mg - contraceptives

קנדה - אנגלית - Health Canada

aspen pharmacare canada inc. - desogestrel; ethinyl estradiol; desogestrel; ethinyl estradiol; desogestrel; ethinyl estradiol - tablet - 0.1mg; 0.025mg; 0.125mg; 0.025mg; 0.15mg; 0.025mg - desogestrel 0.1mg; ethinyl estradiol 0.025mg; desogestrel 0.125mg; ethinyl estradiol 0.025mg; desogestrel 0.15mg; ethinyl estradiol 0.025mg - contraceptives

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - desogestrel micronized, ethinylestradiol micronized - film coated tablet - 150/20 microgram - progestogens and estrogens, fixed combinations

ארצות הברית - אנגלית - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - reclipsen™ (desogestrel and ethinyl estradiol tablets usp) is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. in a clinical trial with reclipsen (desogestrel and ethinyl estradiol tablets usp), 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. this represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. this rate includes patients who did not take the drug correctly. table 1: percentage of women experiencing an unintended pregnancy during the first year of typi

ארצות הברית - אנגלית - NLM (National Library of Medicine)

par pharmaceutical - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.15 mg - kimidess® is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. table ii: percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year, united states.    % of women experiencing an unintended pregnancy within the first year of use   % of women continuing use at one year 3 adapted from hatcher et al., 1998, ref#1. 1 among typical couples who initiate use of a method (not necessarily for the first time), the percentage who experience

ארצות הברית - אנגלית - NLM (National Library of Medicine)

glenmark pharmaceuticals inc., usa - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.15 mg - oral contraceptives should not be used in women who currently have the following conditions:

ארצות הברית - אנגלית - NLM (National Library of Medicine)

a-s medication solutions - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - apri® (desogestrel and ethinyl estradiol tablets usp) is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. in a clinical trial with apri (desogestrel and ethinyl estradiol tablets usp), 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. this represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. this rate includes patients who did not take the drug correctly. table 1: percentage of women experiencing an unintended pregnancy during the first year of typical use a